Literature DB >> 7788296

The catalytic site of serine proteinases as a specific binding cavity for xenon.

M Schiltz1, R Fourme, I Broutin, T Prangé.   

Abstract

BACKGROUND: Under moderate pressure, xenon can bind to proteins and form weak but specific interactions. Such protein-xenon complexes can be used as isomorphous derivatives for phase determination in X-ray crystallography.
RESULTS: Investigation of the serine proteinase class of enzymes shows that the catalytic triad, the common hydrolytic motif of these enzymes, is a specific binding site for one xenon atom and shows high occupancy at pressures below 12 bar. Complexes of xenon with two different serine proteinases, elastase and collagenase, were analyzed and refined to 2.2 A and 2.5 A resolution, respectively. In both cases, a single xenon atom with a low temperature factor is located in the active site at identical positions. Weak interactions exist with several side chains of conserved amino acids at the active site. Xenon binding does not induce any major changes in the protein structure and, as a consequence, crystals of the xenon complexes are highly isomorphous with the native protein structures. Xenon is also found to bind to the active site of subtilisin Carlsberg, a bacterial serine proteinase, that also has a catalytic triad motif.
CONCLUSIONS: As the region around the active site shows conserved structural homology in all serine proteinases, it is anticipated that xenon binding will prove to be a general feature of this class of proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7788296     DOI: 10.1016/s0969-2126(01)00161-7

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  9 in total

1.  Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?

Authors:  Benoît Haelewyn; Jean-Jacques Risso; Jacques H Abraini
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-10       Impact factor: 6.200

2.  Analysis of substrate access to active sites in bacterial multicomponent monooxygenase hydroxylases: X-ray crystal structure of xenon-pressurized phenol hydroxylase from Pseudomonas sp. OX1.

Authors:  Michael S McCormick; Stephen J Lippard
Journal:  Biochemistry       Date:  2011-12-02       Impact factor: 3.162

3.  A Structural Basis for 129 Xe Hyper-CEST Signal in TEM-1 β-Lactamase.

Authors:  Benjamin W Roose; Serge D Zemerov; Yanfei Wang; Marina A Kasimova; Vincenzo Carnevale; Ivan J Dmochowski
Journal:  Chemphyschem       Date:  2018-09-13       Impact factor: 3.102

4.  Study of the complex between the contrast agent Iobitridol (Xenetix) and Elastase (PPE): a model for hydrophobic site protection in drug-protein interactions.

Authors:  T Prangé; A Neuman; C Corot; D Meyer
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

5.  Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.

Authors:  Hélène N David; Benoît Haelewyn; Jean-Jacques Risso; Nathalie Colloc'h; Jacques H Abraini
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

6.  Gas chromatography/mass spectrometry measurement of xenon in gas-loaded liposomes for neuroprotective applications.

Authors:  Melvin E Klegerman; Melanie R Moody; Jermaine R Hurling; Tao Peng; Shao-Ling Huang; David D McPherson
Journal:  Rapid Commun Mass Spectrom       Date:  2017-01-15       Impact factor: 2.419

7.  Crystal structure of glycyl-tRNA synthetase from Thermus thermophilus.

Authors:  D T Logan; M H Mazauric; D Kern; D Moras
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

8.  Antiapoptotic activity of argon and xenon.

Authors:  Sabrina Spaggiari; Oliver Kepp; Santiago Rello-Varona; Kariman Chaba; Sandy Adjemian; Jan Pype; Lorenzo Galluzzi; Marc Lemaire; Guido Kroemer
Journal:  Cell Cycle       Date:  2013-07-16       Impact factor: 4.534

9.  Inert Gas Deactivates Protein Activity by Aggregation.

Authors:  Lijuan Zhang; Yuebin Zhang; Jie Cheng; Lei Wang; Xingya Wang; Meng Zhang; Yi Gao; Jun Hu; Xuehua Zhang; Junhong Lü; Guohui Li; Renzhong Tai; Haiping Fang
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.